Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q1 2018 · 10-Q
Revenue$63.42M$63.42M+10.4% vs Q1 2017 Net Income$644.00K$644.00KN/M vs Q1 2017 EPS Diluted-$0.03-$0.03N/M vs Q1 2017 Gross Profit$27,303,000+19.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flow$14,312,000N/M Free Cash Flowderived$9,646,000N/M Margins · derivedGross margin43.0%+3.1 pt vs Q1 2017
Operating margin3.9%+5.0 pt vs Q1 2017
Net margin1.0%+3.0 pt vs Q1 2017
ended Mar 31, 2018 · filed May 8, 2018 · 38 d after period end